Normal
0
false
false
false
EN-US
X-NONE
AR-SA
MicrosoftInternetExplorer4
Background: Amphibian
skins possess various antibacterial compounds that are effective against some
microbial pathogens and are mostly released in response to environmental
stress. In fact, the skin of Rana ridibunda, a large green frog, is a
rich source of antimicrobial compounds that can be developed for therapeutic
use. In the present study, the skin extract of Iranian Rana ridibunda was
evaluated for its antimicrobial, hemolytic and cytototoxic activities.
Methods : The frog specimens were collected from Minoodasht located in Golesten
province in Iran, during 2009. Subsequently, their skins were removed and the intended compounds
were extracted. The crude extract was partially purified by gel filtration
chromatography. The antimicrobial effects of skin extract were assessed against
various microorganisms such as Escherchia coli, methicillin-resistant
and -sensitive Staphyloccus aureus, vancomycin-resistant and -susceptible
Enteroccus fecalis, Pseudomonas aeroginosa and Candida albicans. In
addition, its minimum inhibition concentration, cytotoxic and hemolytic
activities were determined.
Results : The crude extract of Rana ridibunda skin had valuable
antimicrobial effects against methicillin-resistant and -susceptible S. aureus in comparison with E.coli and vancomycin-resistant
and -susceptible E. fecalis. Besides, no
antimicrobial activities were seen against P. aeroginosa or C. albicans. Moreover, the hemolytic and cytotoxic activities of the skin
extract were minimal.
Conclusion: The
antimicrobial activity of Iranian Rana ridibunda was comparable to those
isolated from other Rana species. In conclusion, the skin extract of Rana
ridibunda had the potential for a new therapeutic agent against the emerging
drug-resistant bacteria, particularly methicillin-resistant and -sensitive S.
aureus.
